Geron Corporation (GERN) Stock Price

0.97 ▼ -0.024 (-2.41%)
Open: 0.99 Vol: 7.1M Day's range: 0.95 - 0.99 Nov 13, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Loading chart ...
GERN Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.97▼ 0.96▼ 0.96▼ 0.99▼ 1.03▼
MA10 0.96▼ 0.96▼ 0.96▼ 0.98▼ 1.15▼
MA20 0.96▼ 0.96▼ 0.98▼ 1.04▼ 1.30▼
MA50 0.96▼ 0.98▼ 0.98▼ 1.18▼ 1.38▼
MA100 0.96▼ 0.99▼ 0.98▼ 1.32▼ 1.55▼
MA200 0.98▼ 0.99▼ 1.09▼ 1.41▼ 2.35▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.000▲ 0.001▲ -0.002▼ 0.007▲ -0.045▼
RSI 44.779▼ 43.460▼ 44.553▼ 40.712▼ 35.529▼
STOCH 49.250     43.253     22.152     50.655     11.589▼
WILL %R -100.000▼ -77.677▼ -82.117▼ -62.857     -83.951▼
CCI -46.127     17.344     -38.355     -23.390     -113.807▼
Latest Filters Detected On GERN
MA $GERN Price Crossed Below MA(13) Set Alert
Geron Corporation News
Monday, November 02, 2026 05:15 AM
Geron achieved FDA approval for RYTELO in June 2024, targeting lower-risk myelodysplastic syndromes. Read what makes GERN stock a compelling Buy.
Wednesday, October 28, 2026 08:40 AM
Geron (GERN) stock falls as the company halts a late-stage trial for its blood cancer therapy imetelstat, marketed as Rytelo. Read more here.
Wednesday, October 28, 2026 01:01 AM
Geron Corporation (Nasdaq: GERN), a commercial-stage hematology biopharmaceutical company, today announced the decision to discontinue the Phase 3 IMpactMF trial evaluating imetelstat in JAK inhibitor ...
GERN historical stock data
date open high low close volume
13/11/26 0.99 0.99 0.95 0.97 7,098,500
12/11/26 1.00 1.02 0.9613 0.994 10,354,729
11/11/26 0.9801 1.02 0.9649 1.02 6,552,375
10/11/26 0.99 1.03 0.94 0.97 12,511,300
09/11/26 0.9929 1.00 0.9739 0.9965 5,732,214
06/11/26 0.95 1.02 0.95 0.99 13,652,100
05/11/26 1.09 1.09 0.929 0.9501 25,758,587
04/11/26 1.01 1.08 0.9611 1.08 26,865,053
03/11/26 0.9411 0.9721 0.9232 0.93 7,447,496
02/11/26 0.90 0.9325 0.8847 0.9291 13,778,022
Quote Details
52wk Low:0.84
52wk High:2.01
Vol:7.1M
Avg Vol(3m):201.3M
1Y Chng:-21.14%
1M Chng:-19.83%
Add to Watch List
More Information
Index US Composite
Market Cap. 640.37M